FDA finds no evidence that Ozempic, similar drugs cause suicidal thoughts in preliminary evaluation
CNN
The US Food and Drug Administration said Thursday that a preliminary evaluation of reports of suicidal thoughts or actions among people taking drugs like Ozempic and Wegovy for type 2 diabetes and weight loss has not found evidence that the drugs cause those effects.
The US Food and Drug Administration said Thursday that a preliminary evaluation of reports of suicidal thoughts or actions among people taking drugs like Ozempic and Wegovy for type 2 diabetes and weight loss has not found evidence that the drugs cause those effects. The agency said in a statement that it conducted “detailed reviews” over the last several months of reports received in its FDA Adverse Event Reporting System, or FAERS. It noted that because “the information was often limited and because these events can be influenced by other factors, we determined that the information in these reports did not demonstrate a clear relationship with the use of GLP-1 (receptor agonists).” GLP-1 receptor agonists are the class of drugs that includes Ozempic and Wegovy, as well as Mounjaro and Zepbound. The FDA also said it reviewed clinical trial results and didn’t find an association. But it noted it couldn’t rule out a “small risk,” since there were so few people who experienced suicidal thoughts or actions in the studies — in both the groups on the medicines and those on placebo — so it said it’s continuing to investigate the issue. Patients should not stop taking GLP-1 drugs without consulting with their health-care providers, and should tell them if they experience depression, suicidal thoughts or any unusual changes in mood or behavior, the FDA said. The agency said last week that it was reviewing reports of people experiencing suicidal thoughts while taking GLP-1 drugs, and evaluating the need for regulatory action. In the same report, the agency said it was also looking into cases of aspiration and alopecia, or hair loss, among people on the medicines.
President-elect Donald Trump has praised the polio vaccine as the “greatest thing,” but a lawyer affiliated with Trump’s pick to lead the country’s top health agency has petitioned the US Food and Drug Administration to revoke approval of the vaccine used in the United States.
Housing the Met’s modern and contemporary art collection from 2030, the new Oscar L. Tang and H.M. Agnes Hsu-Tang Wing is the first in the museum’s 154-year history to be designed by a female architect.
Robert Eggers’ remake of the horror classic is an all-encompassing psychosexual nightmare — and the bursting bodices only add to the film’s fever pitch.
Most women in the United States haven’t received birth control prescriptions or other family planning services in recent years, a new report suggests, even as abortion restrictions have grown.
Testing for high-risk human papillomaviruses every five years – even with a self-collected sample – is the “preferred screening strategy” for cervical cancer starting at age 30, according to a new draft recommendation from the US Preventive Services Task Force.
The Russian-born, American artist has garnered critical acclaim for her subtle, unnerving images of Florida’s collapsing pastel-pink landscapes.
Thanks to effective and popular new drugs for weight loss and diabetes – an estimated 1 in 8 adults in the US has used Ozempic or a similar GLP-1 medication – demand for procedures to lift and tighten skin has surged.
Pantone has named an “evocative soft brown” called Mocha Mousse its color of the year for 2025.
Anesthesiologists are raising alarm about an insurance company’s plan to limit the amount time they cover for anesthesia used in surgeries and procedures. One major professional group of anesthesiologists is calling for immediate reversal of the “unprecedented move,” saying it’s egregious and uninformed.
British luxury automaker Jaguar has revealed its Type 00 concept car, the first glimpse of a new electric vehicle following a controversial rebrand that has divided opinion on social media.
The Supreme Court on Wednesday heard the Biden administration’s challenge to a transgender care ban in Tennessee. Listen to the audio live and follow here for the latest live news updates.